Contemporary Treatment Approaches for non-Melanoma Skin Cancer of the Head and Neck - On Demand

Originally recorded May 7, 2025, this complimentary one-hour virtual presentation and Q&A on indications and new concepts in systemic therapy for head and neck non-melanoma keratinizing skin cancer, is now available on demand. This CME-accredited session features insights from MSK’s specialists:

• Thomas J. Ow MD, MS, Head and Neck Surgeon

• Michael Hwang, MD, Head and Neck Medical Oncologist

This presentation is part of a complimentary series hosted by MSK’s Physician Relations Team, designed to provide valuable updates and insights across a wide range of topics led by MSK faculty experts.

1. Understand the difference between technical and functional resectability in light of treatment options for non-melanoma skin cancer
2. Review surgical planning after neoadjuvant therapy for non-melanoma skin cancer
3. Address systemic therapy for locally advanced and metastatic non-melanoma skin cancer and clinical trials focused on neoadjuvant approaches for non-melanoma skin cancer

This on demand is complimentary for all participants. An account is required to to access the video and claim credit. Click the 'Course Content' tab at the top of the page for complete instructions. Access to the recording and the ability to claim credit will remain available through June 9, 2026.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this on demand for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded/Review Date: May 7, 2025 | Original Release Date: June 9, 2025 | Termination Date: June 9, 2026

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.